This Week Last Year in Medtech: March 26 – April 1
See what ActiGraft, Embecta, and VNS were up to this time last year.
VNS Makes an Impact in Costs for Children with Epilepsy
The study was from Ann & Robert H. Lurie Children's Hospital of Chicago and published in the journal Epilepsia.
Lessons from the Evolution of the Automated External Defibrillator
Researchers credit rapid prototyping and user-centric design key to developing the small, light, and portable automated external defibrillator.
Novel Wound Care Systems Shipped to Ukraine
ActiGraft blood-clotting wound care systems were developed to treat trauma and other injuries.
Some Diagnostics Companies Can Breathe a Sigh of Relief
Companies that sell 510(K) cleared diagnostic products in the United States may have a head start on meeting the EU Commission's new IVDR requirements.
Poland Gets Its First Robotic Electrophysiology Program
Poland’s National Institute of Cardiology has established the first robotic electrophysiology program in the country with a Stereotaxis system.
Embecta Is the New/Old Kid on the Block in Diabetes
Embecta’s CEO Devdatt Kurdikar joins us for this episode of Let’s Talk Medtech, to discuss being spun out from Becton Dickinson and how its rich history gives it an advantage in the diabetes market.
Could Vagal Nerve Stim Reduce Post-Op Afib?
New findings from the Feinstein Institutes for Medical Research could lead to better options to avoid arrythmias that can arise after cardiac surgery.
About the Author
You May Also Like